FindTrial
Sign In

Preparation and Imaging Study of 64Cu-NOTA-JR11 PET Molecular Probe for Somatostatin Receptor Antagonism

Preparation and Imaging Study of 64Cu-NOTA-JR11 PET Molecular Probe for Somatostatin Receptor Antagonism - Preparation and Imaging Study of 64Cu-NOTA-JR11 PET

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092064
Enrollment
Unknown
Registered
2024-11-08
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuroendocrine Neoplasms

Interventions

Case series:None

Sponsors

Affiliated Hopstial of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Meet the following criteria: the party is entitled to participate in trial ? volunteered to join the study, participants signed informed consent; ? Age =18 years; ? ECOG PS: 0 ~ 1; ? with histopathological diagnosis of neuroendocrine tumor, including a well-differentiated neuroendocrine tumor and poorly differentiated neuroendocrine carcinoma; ? At least measurable lesions as defined by RECIST 1.1; ? expected survival period for 3 months or more.

Exclusion criteria

Exclusion criteria: Any of the following is true of patients will be out of test: ? for any reason cannot accept nuclide inspectors; ? pregnancy or lactation women; ? Patients with hepatic and renal insufficiency; ? vital signs is not smooth.

Design outcomes

Primary

MeasureTime frame
Size and number of lesions;SUVmax;—

Secondary

MeasureTime frame
The human body radiation dosimetry;—

Countries

China

Contacts

Public ContactYang Fanhui

Affiliated Hopstial of North Sichuan Medical College

499429570@qq.com+86 134 0817 7089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026